Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

Articles published in
J Gen Virol
    May 2021
  1. THE MICROBIOLOGY SOCIETY
    Retraction notice: Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes.
    J Gen Virol. 2021;102.
    >> Share

    March 2021
  2. BREITINGER U, Farag NS, Ali NKM, Ahmed M, et al
    Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    J Gen Virol. 2021 Mar 12. doi: 10.1099/jgv.0.001571.
    >> Share

  3. FERNANDES CAMPOS GR, Ward J, Chen S, Bittar C, et al
    Corrigendum: A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir.
    J Gen Virol. 2021;102.
    >> Share

  4. SIMMONDS P, Williams S, Harvala H
    Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    J Gen Virol. 2021;102.
    >> Share

    November 2020
  5. KALEMERA MD, Capella-Pujol J, Chumbe A, Underwood A, et al
    Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins.
    J Gen Virol. 2020 Nov 4. doi: 10.1099/jgv.0.001512.
    >> Share

  6. FERNANDES CAMPOS GR, Ward J, Chen S, Bittar C, et al
    A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir.
    J Gen Virol. 2020 Nov 3. doi: 10.1099/jgv.0.001496.
    >> Share

    September 2020
  7. WARD JC, Bowyer S, Chen S, Fernandes Campos GR, et al
    Insights into the unique characteristics of hepatitis C virus genotype 3 revealed by development of a robust sub-genomic DBN3a replicon.
    J Gen Virol. 2020 Sep 8. doi: 10.1099/jgv.0.001486.
    >> Share

  8. BAMFORD CGG, McLauchlan J
    An interferon lambda 4-associated variant in the hepatitis C virus RNA polymerase affects viral replication in infected cells.
    J Gen Virol. 2020 Sep 8. doi: 10.1099/jgv.0.001495.
    >> Share

    December 2019
  9. WATANABE N, Suzuki T, Date T, Hussan HA, et al
    Establishment of infectious genotype 4 cell culture-derived hepatitis C virus.
    J Gen Virol. 2019 Dec 20. doi: 10.1099/jgv.0.001378.
    >> Share

  10. JOHRI MK, Lashkari HV, Gupta D, Vedagiri D, et al
    mTORC1 restricts hepatitis C virus RNA replication through ULK1-mediated suppression of miR-122 and facilitates post-replication events.
    J Gen Virol. 2019 Dec 10. doi: 10.1099/jgv.0.001356.
    >> Share

  11. GOONAWARDANE N, Yin C, Harris M
    Phenotypic analysis of mutations at residue 146 provides insights into the relationship between NS5A hyperphosphorylation and hepatitis C virus genome replication.
    J Gen Virol. 2019 Dec 10. doi: 10.1099/jgv.0.001366.
    >> Share

    October 2019
  12. THE MICROBIOLOGY SOCIETY
    Retraction notice: Hepatitis C virus activates interleukin-1beta via caspase-1-inflammasome complex.
    J Gen Virol. 2019 Oct 24. doi: 10.1099/jgv.0.001339.
    >> Share

  13. THE MICROBIOLOGY SOCIETY
    Retraction notice: Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.
    J Gen Virol. 2019 Oct 21. doi: 10.1099/jgv.0.001340.
    >> Share

    August 2019
  14. BEECH H
    Expression of concern: Hepatitis C virus activates interleukin-1beta via caspase-1-inflammasome complex.
    J Gen Virol. 2019 Aug 23. doi: 10.1099/jgv.0.001313.
    >> Share

  15. BEECH H
    Expression of concern: Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.
    J Gen Virol. 2019 Aug 20. doi: 10.1099/jgv.0.001312.
    >> Share

    June 2019
  16. OSAWA M, Uchida T, Imamura M, Teraoka Y, et al
    Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
    J Gen Virol. 2019 Jun 14. doi: 10.1099/jgv.0.001268.
    >> Share

    May 2019
  17. SHUI J, Liu W, Liang Y, Zhang J, et al
    Infection of human pegivirus 2 (HPgV-2) is associated with hepatitis C virus but not hepatitis B virus infection in people who inject drugs.
    J Gen Virol. 2019 May 15. doi: 10.1099/jgv.0.001266.
    >> Share

    January 2019
  18. BERNIER A, Sagan SM
    Beyond sites 1 and 2, miR-122 target sites in the HCV genome have negligible contributions to HCV RNA accumulation in cell culture.
    J Gen Virol. 2019 Jan 17. doi: 10.1099/jgv.0.001217.
    >> Share

  19. BUKOWSKA-OSKO I, Perlejewski K, Caraballo Cortes K, Pollak A, et al
    Corrigendum: Next-generation Sequencing Analysis of New Genotypes Appearing During Antiviral Treatment of Chronic Hepatitis C Reveals that These Are Selected from Pre-existing Minor Strains.
    J Gen Virol. 2019 Jan 11. doi: 10.1099/jgv.0.001225.
    >> Share

    December 2018
  20. ZHANG Y, Zou J, Zhao X, Yuan Z, et al
    Hepatitis C virus NS5A inhibitor daclatasvir allosterically impairs NS4B-involved protein-protein interactions within the viral replicase and disrupts the replicase quaternary structure in a replicase assembly surrogate system.
    J Gen Virol. 2018 Dec 5. doi: 10.1099/jgv.0.001180.
    >> Share

    November 2018
  21. GAMBATO M, Gregori J, Quer J, Koutsoudakis G, et al
    Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation.
    J Gen Virol. 2018 Nov 19. doi: 10.1099/jgv.0.001175.
    >> Share

  22. IWONA BO, Karol P, Kamila CC, Pollak A, et al
    Next-generation sequencing analysis of new genotypes appearing during antiviral treatment of chronic hepatitis C reveals that these are selected from pre-existing minor strains.
    J Gen Virol. 2018 Nov 5. doi: 10.1099/jgv.0.001160.
    >> Share

    October 2018
  23. MORI H, Fukuhara T, Ono C, Tamura T, et al
    Induction of selective autophagy in cells replicating hepatitis C virus genome.
    J Gen Virol. 2018 Oct 12. doi: 10.1099/jgv.0.001161.
    >> Share

    July 2018
  24. SHIRASAGO Y, Fukazawa H, Aizaki H, Suzuki T, et al
    Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
    J Gen Virol. 2018 Jul 25. doi: 10.1099/jgv.0.001117.
    >> Share

  25. DA SILVA MS, Junqueira DM, Baumbach LF, Cibulski SP, et al
    Comprehensive evolutionary and phylogenetic analysis of Hepacivirus N (HNV).
    J Gen Virol. 2018;99:890-896.
    >> Share

    June 2018
  26. MEJER N, Fahnoe U, Galli A, Ramirez S, et al
    Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a.
    J Gen Virol. 2018 Jun 21. doi: 10.1099/jgv.0.001095.
    >> Share

    January 2018
  27. BELDAR S, Manimekalai MSS, Cho NJ, Baek K, et al
    Self-association and conformational variation of NS5A domain 1 of hepatitis C virus.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.001000.
    >> Share

    December 2017
  28. ORDEIG L, Garcia-Cehic D, Gregori J, Soria ME, et al
    New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors.
    J Gen Virol. 2017 Dec 14. doi: 10.1099/jgv.0.000996.
    >> Share

  29. LI Z, Liu Q
    Proprotein convertase subtilisin/kexin type 9 inhibits hepatitis C virus replication through interacting with NS5A.
    J Gen Virol. 2017 Dec 13. doi: 10.1099/jgv.0.000987.
    >> Share

  30. RADKOWSKI M, Opoka-Kegler J, Cortes KC, Bukowska-Osko I, et al
    Corrigendum: Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin.
    J Gen Virol. 2017;98:3122.
    >> Share

    November 2017
  31. GOONAWARDANE N, Ross-Thriepland D, Harris M
    Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein.
    J Gen Virol. 2017 Nov 15. doi: 10.1099/jgv.0.000975.
    >> Share

    October 2017
  32. KELLY L, Badhan A, Roberts GC, Mbisa JL, et al
    Manipulation of both virus- and cell-specific factors is required for robust transient replication of a hepatitis C virus genotype 3a sub-genomic replicon.
    J Gen Virol. 2017 Oct 6. doi: 10.1099/jgv.0.000932.
    >> Share

    August 2017
  33. YANG CH, Li HC, Ku TS, Wu PC, et al
    Hepatitis C virus down-regulates SERPINE1/PAI-1 expression to facilitate its replication.
    J Gen Virol. 2017 Aug 31. doi: 10.1099/jgv.0.000901.
    >> Share

    July 2017
  34. FENG Y, Feng YM, Lu C, Han Y, et al
    Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo.
    J Gen Virol. 2017 Jul 31. doi: 10.1099/jgv.0.000869.
    >> Share

  35. MANUYLOV VA, Chub EV, Kichatova VS, Soboleva NV, et al
    Hepatitis C virus subtype 3a was introduced in the USSR in the early 1980s.
    J Gen Virol. 2017 Jul 26. doi: 10.1099/jgv.0.000878.
    >> Share

  36. GRIGOROV B, Molle J, Rubinstein E, Zoulim F, et al
    CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000850.
    >> Share

  37. KASSELA K, Karakasiliotis I, Charpantidis S, Koskinas J, et al
    High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
    J Gen Virol. 2017 Jul 15. doi: 10.1099/jgv.0.000851.
    >> Share

  38. CAMPOS GRF, Bittar C, Jardim ACG, Shimizu JF, et al
    Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
    J Gen Virol. 2017 Jul 12. doi: 10.1099/jgv.0.000808.
    >> Share

  39. YI Z, Yuan Z
    Aggregation of a hepatitis C virus replicase module induced by ablation of p97/VCP.
    J Gen Virol. 2017 Jul 10. doi: 10.1099/jgv.0.000828.
    >> Share

    June 2017
  40. HULLEGIE SJ, Arends JEA, Groothuismink ZMA, Pas SD, et al
    Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients.
    J Gen Virol. 2017 Jun 8. doi: 10.1099/jgv.0.000768.
    >> Share

    May 2017
  41. RAJ M, Langley M, McArthur SJ, Jean F, et al
    Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells.
    J Gen Virol. 2017 May 26. doi: 10.1099/jgv.0.000754.
    >> Share

    February 2017
  42. DAS S, Mullick R, Kumar A, Tandon H, et al
    Identification of a novel epitope in the C-terminus of HCV-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    J Gen Virol. 2017 Feb 3. doi: 10.1099/jgv.0.000735.
    >> Share

  43. NAIK AS, Palmer BA, Crosbie O, Kenny-Walsh E, et al
    Humoral immune system targets clonotypic antibody-associated hepatitis C virus.
    J Gen Virol. 2017;98:179-189.
    >> Share

    January 2017
  44. UCHIDA T, Imamura M, Kan H, Hiraga N, et al
    Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
    J Gen Virol. 2017 Jan 28. doi: 10.1099/jgv.0.000726.
    >> Share

  45. VENTURA M, Martin L, Jaubert C, Andreola ML, et al
    HCV intragenomic interactions are modulated by the SLVI RNA structure of the core coding sequence.
    J Gen Virol. 2017 Jan 27. doi: 10.1099/jgv.0.000719.
    >> Share

    December 2016
  46. NIEDER-ROHRMANN A, Dunnes N, Gerresheim GK, Shalamova LA, et al
    Cooperative enhancement of translation by two adjacent microRNA-122/Argonaute 2 complexes binding to the 5 untranslated region of Hepatitis C Virus RNA.
    J Gen Virol. 2016 Dec 23. doi: 10.1099/jgv.0.000697.
    >> Share

  47. FLETCHER N, Clark AR, Balfe P, McKeating J, et al
    TNF superfamily members promote hepatitis C virus entry via an NF-kappaB and myosin light chain kinase dependent pathway.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000689.
    >> Share

    November 2016
  48. NAIK AS, Palmer BA, Crossbie O, Kenny-Walsh E, et al
    Humoral immune system targets clonotypic antibody associated Hepatitis C Virus.
    J Gen Virol. 2016 Nov 14. doi: 10.1099/jgv.0.000659.
    >> Share

  49. KWAK J, Tiwari I, Jang KL
    Hepatitis C virus Core activates proteasomal activator 28 gamma expression via upregulation of p53 levels to control virus propagation.
    J Gen Virol. 2016 Nov 11. doi: 10.1099/jgv.0.000655.
    >> Share

  50. ZHANG H, Zhang J, Chen L, Weng Z, et al
    Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
    J Gen Virol. 2016 Nov 11. doi: 10.1099/jgv.0.000656.
    >> Share

  51. SMITH DB, Becher P, Bukh J, Gould EA, et al
    Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family.
    J Gen Virol. 2016;97:2894-2907.
    >> Share

    October 2016
  52. JIAO XY, Steenbergen RH, Tyrrell DL
    The use of human umbilical cord blood serum is beneficial for the continuous production of hepatitis C virus.
    J Gen Virol. 2016 Oct 24. doi: 10.1099/jgv.0.000636.
    >> Share

    September 2016
  53. WASILEWSKI L, Ray S, Bailey JR
    Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication competent virus and pseudoparticles.
    J Gen Virol. 2016 Sep 21. doi: 10.1099/jgv.0.000608.
    >> Share

  54. DU X, Pan T, Xu J, Zhang Y, et al
    Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5.
    J Gen Virol. 2016 Sep 16. doi: 10.1099/jgv.0.000607.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016